Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension

Heart Disease and Stroke Statistics—2010 Update

Donald M. Lloyd‐Jones, Robert J. Adams, Todd M. Brown et al. · Circulation · 2009 · 5.6K citations

Medicine, Cardiology, Disease Surveillance +10

Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic Analysis

IvanV Gregoretti, Yunmi Lee, Holly V. Goodson · Journal of Molecular Biology · 2004 · 1.5K citations

Life Sciences, Genetics, Molecular Biology +14

Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1

Kevin J. Bitterman, Rozalyn M. Anderson, Haim Cohen et al. · Journal of Biological Chemistry · 2002 · 998 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

Laimute Taraseviciene‐Stewart, Yasunori Kasahara, Lori Alger et al. · The FASEB Journal · 2001 · 807 citations

Medicine, Pharmacology, Apoptosis +15

Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Kyle V. Butler, Jay H. Kalin, Camille Brochier et al. · Journal of the American Chemical Society · 2010 · 772 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16